Search results
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 1 day agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies in combating the virus ...
Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'
Rolling Stone· 4 days agoA hearing in the House Oversight Committee once again devolved into chaos as Republican lawmakers...
...Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with...
KOIN News 6 Portland· 5 days ago...that develops, manufactures and commercializes high-quality medicines for the treatment of...
Annexon shares leap as Guillain-Barré drug reduces disability in phase 3
FierceBiotech· 3 days agoAnnexon’s monoclonal antibody ANX005 reduced disability in patients with the rare autoimmune...
Humans May Be Able to Grow New Teeth Within Just 6 Years
Popular Mechanics via Yahoo News· 4 days agoBack in 2021, scientists from the Kyoto University—who will also be involved in future human...
A Guide to Managing Covid This Summer
New York Times· 4 days agoHere’s what to know about symptoms, testing and treatment. KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers...
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
FierceBiotech· 1 day agoThe docs for Eli Lilly’s donanemab advisory committee meeting are in: the FDA has raised concerns...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
The Woonsocket Call· 6 days agoSugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous ...
EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC
Pharmaceutical Technology via Yahoo Finance· 4 days agoCStone's sugemalimab has been recommended in combination with chemotherapy as a first-line treatment...
How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?
Medscape· 2 days agoNew data on clazakizumab, a monoclonal antibody targeting interleukin-6 (IL-6), and home...